Establishing Pompe Disease Newborn Screening: The Role of Industry
When clinical trials for enzyme replacement therapy for Pompe disease commenced, a need for newborn screening (NBS) for Pompe disease was recognized. Two methods for NBS for Pompe disease by measuring acid α-glucosidase in dried blood spots on filter paper were developed in an international collabor...
Main Author: | Joan M. Keutzer |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-07-01
|
Series: | International Journal of Neonatal Screening |
Subjects: | |
Online Access: | https://www.mdpi.com/2409-515X/6/3/55 |
Similar Items
-
Newborn Screening for Pompe Disease: Pennsylvania Experience
by: Can Ficicioglu, et al.
Published: (2020-11-01) -
Newborn screening for Pompe disease in Italy: Long-term results and future challenges
by: Vincenza Gragnaniello, et al.
Published: (2022-12-01) -
The First Year Experience of Newborn Screening for Pompe Disease in California
by: Hao Tang, et al.
Published: (2020-02-01) -
Muscle ultrasound in patients with late-onset Pompe disease identified by newborn screening
by: David G. Jackson, et al.
Published: (2023-09-01) -
Lessons Learned from Pompe Disease Newborn Screening and Follow-up
by: Tracy L. Klug, et al.
Published: (2020-02-01)